19Aug/13

Children's Cancer Recovery Foundation Reveals New Antibodies that May Fight … – EIN News (press release)

Children’s Cancer Recovery Foundation Reveals New Antibodies that May Fight
EIN News (press release)
The article explains that they “have developed two monoclonal antibodies called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.” The antibodies bind to different molecules in the immune system and stimulate its response in

and more »

19Aug/13

Market Access Granted in France for Aggressive non-Hodgkin Lymphoma … – The Herald | HeraldOnline.com

Market Access Granted in France for Aggressive non-Hodgkin Lymphoma
The Herald | HeraldOnline.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who 
CELL THERAPEUTICS INC : Market Access Granted in France for Aggressive 4-traders (press release)

all 7 news articles »